Ocean Biomedical Price To Sales Ratio Over Time

OCEA Stock   0.70  0.01  1.41%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Ocean Biomedical Performance and Ocean Biomedical Correlation.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
  
At present, Ocean Biomedical's Book Value Per Share is projected to increase slightly based on the last few years of reporting. The current year's Net Income Per Share is expected to grow to 0.02, whereas Common Stock Shares Outstanding is forecasted to decline to about 24.8 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.00)
Return On Assets
(6.82)
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Price To Sales Ratio Analysis

Compare Ocean Biomedical and related stocks such as Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology Price To Sales Ratio Over Time
Select Fundamental
Price To Sales RatioPtb Ratio
Days Sales OutstandingBook Value Per Share
Free Cash Flow YieldInvested Capital
Operating Cash Flow Per ShareAverage Payables
Stock Based Compensation To RevenueCapex To Depreciation
Pb RatioEv To Sales
Free Cash Flow Per ShareInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Ev To Free Cash FlowIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Dividend YieldRoic
Payables TurnoverRoe
Return On Tangible AssetsEarnings Yield
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Capital Employed
Return On AssetsAsset Turnover
Return On Equity
201020112012201320142015201620172018201920202021202220232024
ENVB28.4 K4.90364.90364.90364.90364.90362.35310.95560.09650.29940.29940.29940.29940.340.33
HEPA0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ELEV0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ZURA0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Ocean Biomedical and related stocks such as Enveric Biosciences, Hepion Pharmaceuticals, and Elevation Oncology Price To Sales Ratio description

Price to Sales Ratio is figured by comparing Ocean Biomedical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Ocean Biomedical sales, a figure that is much harder to manipulate than other Ocean Biomedical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

My Equities

My Current Equities and Potential Positions

Ocean Biomedical
OCEA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationNew York; U.S.A
ExchangeNASDAQ Exchange
null 0.7
When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:
Check out Ocean Biomedical Performance and Ocean Biomedical Correlation.
For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Ocean Biomedical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Ocean Biomedical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Ocean Biomedical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...